CANO/ACIO Annual Conference 2012 Conférence annuelle ACIO/CANO 2012 Photo Credit: Tourism Ottawa 2012 Oncology Nurses: Advocates by Profession Les infirmières en oncologie: porte-parole par excellence The Westin Hotel Ottawa, Ontario, Canada Canadian Association of Nurses in Oncology October 11-14, 2012 Association canadienne des infirmières en oncologie 11 au 14 octobre 2012 ROCHE_AD-1pV_ENG 3/23/06 2:39 PM Page 1 An investment in research is an investment in hope. Roche is a leader in the research and development of pharmaceutical and diagnostic solutions that look beyond today’s horizons and make a profound difference in people’s lives. Working in partnership with healthcare practitioners from across the country, we have opened the door to countless new possibilities in the discovery, treatment and management of acute and long-term disease. www.rochecanada.com Registered Trade-Mark of Hoffmann-La Roche Limited 2 CANO/ACIO 2012 Conference Ottawa, Thursday, October 11 to Sunday, October 14, 2012 ! ! ! "! # " !!! $ Ottawa, Thursday, October 11 to Sunday, October 14, 2012 CANO/ACIO Conference 2012 3 Size: (H) 11 x (W) 8.5 Created by: Michelle Irvine Submission due date: 05/06/2012 Publication/event: CANO/ACIO Conference 2012 Booklet on 11/10/2012 We share your commitment to improving the lives of cancer patients and are proud to be a sponsor of the 2012 CANO Conference. Nous partageons votre engagement à améliorer la vie des patients atteints du cancer et nous sommes un fier commanditaire de la Conférence 2012 de l’ACIO. Pr Pr PrPr thalidomide capsules lenalidomide capsules capsules de thalidomide capsules de lénalidomide ® © 20124 CelgeneCANO/ACIO Inc. Revlimid, Thalomid, 2012 Vidaza C andon Abraxanefere are registerednce trademarks Ottawa, of CelgeneThursday, Corporation. October 11 to Sunday, October 14, 2012 CEL1210-CANO Ad_P00.indd 1 12-08-24 2:20 PM vx120038_08_01EF_JAN_Corporate_Ads_CANO-ACIO_Conference_2012.pdf 1 12-05-24 3:29 PM Our purpose: As a member of the Janssen Pharmaceutical Make a difference C Companies of Johnson & Johnson, Janssen Inc. M is dedicated to addressing and solving the most Y important unmet medical needs of our time. Driven CM by our commitment to the passionate pursuit of MY science for the benefit of patients, we work together CY to bring innovative ideas, products and services to CMY K patients across Canada and around the world. Nous mettons la À titre de membre du groupe des entreprises science au service pharmaceutiques Janssen de Johnson & Johnson, Janssen Inc. s’emploie à répondre aux besoins des patients non satisfaits les plus importants de notre temps. Poussés par notre passion de mettre la science au service des patients, nous collaborons à de nouvelles Betsy Gross, Lilies and Carp solutions, produits et services pour le bien des Artwork from The Creative Center Janssen is proud to feature artwork created by people affected by the illnesses patients dans le monde entier. and diseases we are committed to treating and preventing. Œuvre créée au The Creative Center Janssen présente avec fierté les œuvres de personnes affectées par les maladies que nous cherchons à traiter et à prévenir. Janssen Inc. 19 Green Belt Drive vx120038EF Toronto, Ontario © JANSSEN Inc. 2012 M3C 1L9 www.janssen.caOttawa, Thursday, October 11 to Sunday, October 14, 2012 CANO/ACIO Conference 2012 5 Sanofi Oncology is dedicated to translating science into effective therapeutics that address unmet medical needs. Starting with a deep understanding of the disease and the patient, Sanofi Oncology employs innovative approaches to drug discovery and clinical development, with the ultimate goal of bringing the right medicines to the right patients to help them live healthier and longer lives. We believe in the value of partnerships that combine our internal scientific expertise with that of industry and academic expert. Our portfolio includes 10 marketed products and more than 15 investigational compounds in clinical development, including small molecules and biological agents. La division Sanofi Oncologie a pour mission de transformer les avancées scientifiques en solutions thérapeutiques efficaces pour répondre aux besoins médicaux non satisfaits. Grâce à une connaissance approfondie de la maladie et du patient, Sanofi Oncologie utilise des approches innovantes pour proposer des édicaments adaptés au profil des patients, afin de les aider à vivre en meilleure santé et plus longtemps. Nous croyons aux partenariats avec des experts de tout premier plan et à l’union de ces expertises avec notre héritage et nos capacités scientifiques propres. Notre portefeuille comprend 10 produits commercialisés et plus de 15 composés en développement clinique, notamment des petites molécules et des agents biologiques. Sponsor & Exhibitor Listing Liste des commanditaires et exposants The 24th CANO/ACIO Annual Conference is made possible by the generous support of the following organizations: La 24ème conférence annuelle de l’ACIO/CANO est rendue possible grâce au généreux soutien des organisations suivantes: Platinum/Platine Gold/Or Silver/Argent Bronze/Bronze Internet Center/Centre Internet Symposia/Symposium Amgen Oncology • Celgene Inc. • Janssen Inc. • Lundbeck Oncology • Pfizer Canada Inc. • SANOFI • Novartis Focus Group/Panel de discussion Takeda Canada Inc. • Roche Canada Award Sponsors/Sponsors des récompenses Amgen Oncology • Boehringer Ingleheim • Brain Tumor Foundation of Canada • Kidney Cancer Canada • Lymphoma Foundation of Canada • Manitoba Chapter of CANO/ACIO • Merck • Ovarian Cancer Canada • Pfizer Canada Inc. • Roche Exhibitors/Autres commmanditaires de la conférence Abbott Laboratories • Abbott Nutrition • Advanced Innovations Inc. Bio Oil • Amgen Oncology • Bard Canada Inc. • Basis Medical Technicologies • Bayer • BD • Beutlich Pharmaceutical LLC • Boehringer Ingleheim • Calmoseptine • Canadian Cancer Society • CANO/ACIO • Celgene • Canadian Nurses Association • Eisai Ltd. • Fertile Future • GSK • Hospira Canada • ICU Medical • Janssen • Kidney Cancer Canada • Leo Pharma • Look Good Feel Better • Lundbeck Oncology • Lung Cancer Canada • Lymphoma Foundation Canada • Merck • Novartis • Oncology Nursing e-Mentorship Program • Oncology Nursing Society • Paladin Labs Inc. • Pendopharm, Division of Pharmascience • Pfizer Canada Inc. • Rethink Breast Cancer • Roche Canada • SANOFI • Smiths Medical Canada • Takeda Canada Inc. 8 CANO/ACIO 2012 Conference Ottawa, Thursday, October 11 to Sunday, October 14, 2012 Table of Contents Sponsor & Exhibitor Listing / Liste des commanditaires et exposants ......................................................... 8 Table of Contents / Table des matières ......................................................................................................... 9 Welcome Notes / Mots de bienvenue .......................................................................................................... 10 Conference Information / Information de conférence ................................................................................ 18 Committee Listing / Liste des membres des comités ................................................................................... 19 About Ottawa / Au sujet d’Ottawa ............................................................................................................. 20 Ottawa Map / Carte d’Ottawa .................................................................................................................... 23 Conference Centre Floor Plan / Plan du conference centre ....................................................................... 24 Exhibitor Floor Plan and Listing / Plan et liste des exposants ................................................................... 25 Conference Program-at-a-Glance / Programme de la conférence d’un coup d’oeil ................................... 26 Committee Meeting Schedule / Horaire des réunion des comités ............................................................... 28 Conference Day One: Thursday, October 11, 2012 / Conférence Jour 1: Jeudi, 11 octobre 2012 .................. 29 Conference Day Two: Friday, October 12, 2012 / Conférence Jour 2: Vendredi, 12 octobre 2012 ................ 34 Conference Day Three: Saturday, October 13, 2012 / Conférence Jour 3: Samedi, 13 octobre 2012 ............. 39 Conference Day Four: Sunday, October 14, 2012 / Conférence Jour 4: Dimanche 14 octobre 2012 ............. 45 Abstract Listing / Liste des abrégés pour présentation orale ..................................................................... 49 Poster Presentations / Séance d’affichage ................................................................................................ 89 Abstract Listings for Poster Presentations / Liste des abrégés pour présentations par affiches ................ 93 Conference Exhibitor Listing / Liste des exposants ................................................................................. 107 Be advised that as in previous years, CANO/ACIO has hired a photographer to document our conference. These photographs may be posted by CANO/ACIO at the closing ceremony on our website, on facebook, twitter, etc. If you do not wish to have your photograph used by CANO/ACIO, please email [email protected]. Ottawa, Thursday, October 11 to Sunday, October 14, 2012 CANO/ACIO Conference 2012 9 10 CANO/ACIO 2012 Conference Ottawa, Thursday, October 11 to Sunday, October 14, 2012 Ottawa, Thursday, October 11 to Sunday, October 14, 2012 CANO/ACIO